
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.5B | $2B | $1.9B | $1.8B | |
Revenue Growth (YoY) | -21.16% | 24.33% | 32.38% | -0.76% | -5.31% | |
Cost of Revenues | $850.4M | $1B | $1.4B | $1.4B | $1.3B | |
Gross Profit | $342.7M | $434.9M | $586.7M | $591.1M | $542.9M | |
Gross Profit Margin | 28.72% | 29.32% | 29.88% | 30.33% | 29.42% | |
R&D Expenses | $30.9M | $37.4M | $38.7M | $41.7M | $47.8M | |
Selling, General & Admin | $237M | $267.2M | $360.7M | $387.8M | $314M | |
Other Inc / (Exp) | -$33.3M | $5.6M | -$900K | $10.5M | -$149.2M | |
Operating Expenses | $267.9M | $304.6M | $399.4M | $429.5M | $361.8M | |
Operating Income | $74.8M | $130.3M | $187.3M | $161.6M | $181.1M | |
Net Interest Expenses | $1.8M | $1.5M | $1.1M | -- | -- | |
EBT. Incl. Unusual Items | $39.7M | $134.4M | $184.6M | $174.4M | $41.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $11M | $41.3M | $51.6M | $35.3M | $5.6M | |
Net Income to Company | $28.7M | $93.1M | $133M | $139.1M | $35.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $28.7M | $93.1M | $133M | $139.1M | $35.6M | |
Basic EPS (Cont. Ops) | $1.17 | $3.78 | $5.37 | $5.60 | $1.43 | |
Diluted EPS (Cont. Ops) | $1.16 | $3.75 | $5.32 | $5.56 | $1.42 | |
Weighted Average Basic Share | $24.6M | $24.6M | $24.8M | $24.9M | $24.9M | |
Weighted Average Diluted Share | $24.8M | $24.9M | $25M | $25M | $25.1M | |
EBITDA | $87.5M | $173M | $227.4M | $200.9M | $224.6M | |
EBIT | $41.5M | $130.3M | $187.3M | $161.6M | $181.1M | |
Revenue (Reported) | $1.2B | $1.5B | $2B | $1.9B | $1.8B | |
Operating Income (Reported) | $74.8M | $130.3M | $187.3M | $161.6M | $181.1M | |
Operating Income (Adjusted) | $41.5M | $130.3M | $187.3M | $161.6M | $181.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $339.6M | $472.4M | $509.6M | $500.2M | $440.8M | |
Revenue Growth (YoY) | -8.78% | 39.11% | 7.88% | -1.85% | -11.88% | |
Cost of Revenues | $238.8M | $333.1M | $361.8M | $344.5M | $315.7M | |
Gross Profit | $100.8M | $139.3M | $147.8M | $155.7M | $125.1M | |
Gross Profit Margin | 29.68% | 29.49% | 29% | 31.13% | 28.38% | |
R&D Expenses | $9M | $10.1M | $10.6M | $14M | $12.7M | |
Selling, General & Admin | $63.6M | $84.9M | $94.5M | $88.8M | $69.4M | |
Other Inc / (Exp) | $3M | $4.3M | $2M | $300K | -$1M | |
Operating Expenses | $72.6M | $95M | $105.1M | $102.8M | $82.1M | |
Operating Income | $28.2M | $44.3M | $42.7M | $52.9M | $43M | |
Net Interest Expenses | $400K | $400K | -- | -- | -- | |
EBT. Incl. Unusual Items | $30.8M | $48.2M | $45M | $55.3M | $44.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.4M | $11.7M | $11.8M | $13.9M | $11.6M | |
Net Income to Company | $23.4M | $36.5M | $33.2M | $41.4M | $32.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $23.4M | $36.5M | $33.2M | $41.4M | $32.8M | |
Basic EPS (Cont. Ops) | $0.95 | $1.47 | $1.34 | $1.66 | $1.31 | |
Diluted EPS (Cont. Ops) | $0.94 | $1.46 | $1.33 | $1.65 | $1.31 | |
Weighted Average Basic Share | $24.6M | $24.8M | $24.8M | $24.9M | $25M | |
Weighted Average Diluted Share | $24.8M | $25M | $25M | $25.1M | $25.1M | |
EBITDA | $41.5M | $54.8M | $52M | $63.3M | $53.9M | |
EBIT | $31.2M | $44.3M | $42.7M | $52.9M | $43M | |
Revenue (Reported) | $339.6M | $472.4M | $509.6M | $500.2M | $440.8M | |
Operating Income (Reported) | $28.2M | $44.3M | $42.7M | $52.9M | $43M | |
Operating Income (Adjusted) | $31.2M | $44.3M | $42.7M | $52.9M | $43M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.6B | $2B | $1.9B | $1.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $830.8M | $1.1B | $1.4B | $1.3B | $1.3B | |
Gross Profit | $329.6M | $473.4M | $595.2M | $599M | $512.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $31.3M | $38.5M | $39.2M | $45.1M | $48.7M | |
Selling, General & Admin | $236.2M | $288.5M | $370.3M | $382.1M | $292.4M | |
Other Inc / (Exp) | -$34.2M | $6.9M | -$3.2M | $8.8M | -$150.5M | |
Operating Expenses | $267.5M | $327M | $409.5M | $427.2M | $341.1M | |
Operating Income | $62.1M | $146.4M | $185.7M | $171.8M | $171.2M | |
Net Interest Expenses | $1.6M | $1.5M | $400K | -- | -- | |
EBT. Incl. Unusual Items | $26.3M | $151.8M | $181.4M | $184.7M | $30.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.3M | $45.6M | $51.7M | $37.4M | $3.3M | |
Net Income to Company | $19M | $106.2M | $129.7M | $147.3M | $27M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $19M | $106.2M | $129.7M | $147.3M | $27M | |
Basic EPS (Cont. Ops) | $0.77 | $4.30 | $5.23 | $5.92 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.74 | $4.26 | $5.19 | $5.89 | $1.06 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $72.2M | $186.3M | $221M | $212.2M | $215.2M | |
EBIT | $27.9M | $143.4M | $182.1M | $171.8M | $171.2M | |
Revenue (Reported) | $1.2B | $1.6B | $2B | $1.9B | $1.8B | |
Operating Income (Reported) | $62.1M | $146.4M | $185.7M | $171.8M | $171.2M | |
Operating Income (Adjusted) | $27.9M | $143.4M | $182.1M | $171.8M | $171.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $339.6M | $472.4M | $509.6M | $500.2M | $440.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $238.8M | $333.1M | $361.8M | $344.5M | $315.7M | |
Gross Profit | $100.8M | $139.3M | $147.8M | $155.7M | $125.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $9M | $10.1M | $10.6M | $14M | $12.7M | |
Selling, General & Admin | $63.6M | $84.9M | $94.5M | $88.8M | $69.4M | |
Other Inc / (Exp) | $3M | $4.3M | $2M | $300K | -$1M | |
Operating Expenses | $72.6M | $95M | $105.1M | $102.8M | $82.1M | |
Operating Income | $28.2M | $44.3M | $42.7M | $52.9M | $43M | |
Net Interest Expenses | $400K | $400K | -- | -- | -- | |
EBT. Incl. Unusual Items | $30.8M | $48.2M | $45M | $55.3M | $44.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.4M | $11.7M | $11.8M | $13.9M | $11.6M | |
Net Income to Company | $23.4M | $36.5M | $33.2M | $41.4M | $32.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $23.4M | $36.5M | $33.2M | $41.4M | $32.8M | |
Basic EPS (Cont. Ops) | $0.95 | $1.47 | $1.34 | $1.66 | $1.31 | |
Diluted EPS (Cont. Ops) | $0.94 | $1.46 | $1.33 | $1.65 | $1.31 | |
Weighted Average Basic Share | $24.6M | $24.8M | $24.8M | $24.9M | $25M | |
Weighted Average Diluted Share | $24.8M | $25M | $25M | $25.1M | $25.1M | |
EBITDA | $41.5M | $54.8M | $52M | $63.3M | $53.9M | |
EBIT | $31.2M | $44.3M | $42.7M | $52.9M | $43M | |
Revenue (Reported) | $339.6M | $472.4M | $509.6M | $500.2M | $440.8M | |
Operating Income (Reported) | $28.2M | $44.3M | $42.7M | $52.9M | $43M | |
Operating Income (Adjusted) | $31.2M | $44.3M | $42.7M | $52.9M | $43M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $105.3M | $141.8M | $147.1M | $203.7M | $289.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $221.4M | $284.5M | $334.6M | $359.8M | $341.7M | |
Inventory | $220M | $277.6M | $373.1M | $300.1M | $301M | |
Prepaid Expenses | $19.1M | $23.8M | $17.4M | $21.5M | $24.1M | |
Other Current Assets | $400K | $400K | $400K | $600K | $600K | |
Total Current Assets | $566.2M | $728.1M | $872.6M | $885.7M | $956.6M | |
Property Plant And Equipment | $250.9M | $249.8M | $266.2M | $313.4M | $314.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $371.2M | $364.3M | $358.8M | $399.3M | $382.5M | |
Other Intangibles | $75.3M | $57.5M | $45M | $57.3M | $65.4M | |
Other Long-Term Assets | $8.2M | $5M | $7.1M | $6.2M | $3.9M | |
Total Assets | $1.4B | $1.6B | $1.6B | $1.7B | $1.7B | |
Accounts Payable | $98.7M | $148.7M | $165.3M | $163.6M | $163.8M | |
Accrued Expenses | $129.8M | $166.5M | $202.9M | $185.9M | $169.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $11.8M | $12.5M | $13.9M | $13.6M | $13.9M | |
Other Current Liabilities | -- | -- | -- | $1.2M | -- | |
Total Current Liabilities | $252.4M | $336.6M | $405.8M | $371.5M | $371.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $452.5M | $537.9M | $563.3M | $557.8M | $518.6M | |
Common Stock | $300K | $300K | $300K | $300K | $300K | |
Other Common Equity Adj | -$57.3M | -$46.9M | -$145.2M | -$148.1M | -$91M | |
Common Equity | $944.4M | $1B | $1B | $1.1B | $1.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $500K | $600K | $2.4M | $2.5M | $4.9M | |
Total Equity | $944.9M | $1B | $1B | $1.1B | $1.2B | |
Total Liabilities and Equity | $1.4B | $1.6B | $1.6B | $1.7B | $1.7B | |
Cash and Short Terms | $105.3M | $141.8M | $147.1M | $203.7M | $289.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $117M | $105.6M | $147.5M | $270.1M | $299.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $247.9M | $337.7M | $342.4M | $318.2M | $343.5M | |
Inventory | $223.1M | $308.2M | $365.7M | $304.3M | $315.4M | |
Prepaid Expenses | $17.3M | $26.7M | $19M | $19.4M | $17M | |
Other Current Assets | $2.3M | $400K | $400K | $900K | $1.4M | |
Total Current Assets | $607.6M | $778.6M | $875M | $912.9M | $977.1M | |
Property Plant And Equipment | $246.6M | $256M | $282.6M | $312.2M | $321.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $367.2M | $362M | $360.2M | $397.5M | $388.4M | |
Other Intangibles | $70.2M | $53M | $46.9M | $57.7M | $72.8M | |
Other Long-Term Assets | $7.5M | $7.2M | $4.9M | $6M | $5M | |
Total Assets | $1.4B | $1.6B | $1.6B | $1.7B | $1.8B | |
Accounts Payable | $114.5M | $161.8M | $177.7M | $166.4M | $169.5M | |
Accrued Expenses | $131.8M | $156.5M | $163.5M | $163.6M | $147.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $12.6M | $14.1M | $15.2M | $13.6M | $14M | |
Other Current Liabilities | -- | -- | -- | $4.5M | -- | |
Total Current Liabilities | $274.3M | $352.3M | $381.6M | $364.9M | $357.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $467M | $554.9M | $543.5M | $546.6M | $508.9M | |
Common Stock | $300K | $300K | $300K | $300K | $300K | |
Other Common Equity Adj | -$67.9M | -$50.5M | -$140.8M | -$155.4M | -$72.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $500K | $700K | $2.4M | $2.6M | $5.7M | |
Total Equity | $959.1M | $1.1B | $1.1B | $1.2B | $1.3B | |
Total Liabilities and Equity | $1.4B | $1.6B | $1.6B | $1.7B | $1.8B | |
Cash and Short Terms | $117M | $105.6M | $147.5M | $270.1M | $299.8M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $28.7M | $93.1M | $133M | $139.1M | $35.6M | |
Depreciation & Amoritzation | $46M | $42.7M | $40.1M | $39.3M | $43.5M | |
Stock-Based Compensation | $5.8M | $4.4M | $6.7M | $8M | $8.5M | |
Change in Accounts Receivable | $74.4M | -$70.3M | -$55.5M | -$12.6M | $4.3M | |
Change in Inventories | $25.5M | -$62M | -$98.5M | $83M | -$11.8M | |
Cash From Operations | $145.9M | $93.2M | $81.7M | $207.3M | $184.5M | |
Capital Expenditures | $29.7M | $39.1M | $42.3M | $77.2M | $62.3M | |
Cash Acquisitions | -- | -- | -- | -$34.7M | -$200K | |
Cash From Investing | -$29.7M | -$36.2M | -$42.1M | -$111.8M | -$62M | |
Dividends Paid (Ex Special Dividend) | -$25.6M | -$28.8M | -$31.7M | -$35.1M | -$38.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $15M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$76.1M | -$600K | -$100K | -$2.3M | -- | |
Repurchase of Common Stock | -$2.1M | -$800K | -$5.9M | -$1.1M | -$700K | |
Other Financing Activities | -$200K | $100K | $1.8M | -$1.4M | $2.1M | |
Cash From Financing | -$86.8M | -$20M | -$33.7M | -$39M | -$35.3M | |
Beginning Cash (CF) | $75.7M | $105.3M | $141.8M | $147.1M | $203.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $29.4M | $37M | $5.9M | $56.5M | $87.2M | |
Ending Cash (CF) | $105.3M | $141.8M | $147.1M | $203.7M | $289.2M | |
Levered Free Cash Flow | $116.2M | $54.1M | $39.4M | $130.1M | $122.2M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $22.4M | $32.3M | $28.9M | $31.2M | -- | |
Depreciation & Amoritzation | $10.3M | $10.3M | $9.9M | $11.1M | -- | |
Stock-Based Compensation | $1.3M | $1.5M | $2M | $2.1M | -- | |
Change in Accounts Receivable | -$33.6M | -$9.2M | $32.4M | $15M | -- | |
Change in Inventories | -$25.8M | -$58.8M | $9.9M | -$11.8M | -- | |
Cash From Operations | -$1.1M | -$7.5M | $55M | $4.7M | -- | |
Capital Expenditures | $9.2M | $9M | $17.3M | $15.3M | -- | |
Cash Acquisitions | -- | -- | -- | -$200K | -- | |
Cash From Investing | -$8.9M | -$9M | -$17.3M | -$15.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$14M | -$15.6M | -$17.2M | -$19M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$100K | -- | -- | -- | -- | |
Repurchase of Common Stock | -$200K | -$1.8M | -$700K | -$300K | -- | |
Other Financing Activities | $100K | -- | -$1.3M | $300K | -- | |
Cash From Financing | -$13M | -$17.2M | -$19.2M | -$18.9M | -- | |
Beginning Cash (CF) | $117M | $105.6M | $147.5M | $270.1M | -- | |
Foreign Exchange Rate Adjustment | $400K | -$500K | -$100K | -$300K | -- | |
Additions / Reductions | -$23M | -$33.7M | $18.5M | -$29.6M | -- | |
Ending Cash (CF) | $94.4M | $71.4M | $165.9M | $240.2M | -- | |
Levered Free Cash Flow | -$10.3M | -$16.5M | $37.7M | -$10.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $19M | $106.2M | $129.7M | $147.3M | $27M | |
Depreciation & Amoritzation | $44.3M | $42.9M | $38.9M | $40.4M | $44M | |
Stock-Based Compensation | $6.2M | $4.5M | $6.9M | $8.2M | $8.3M | |
Change in Accounts Receivable | $51.6M | -$92.5M | -$8.6M | $32.9M | -$28.6M | |
Change in Inventories | $25M | -$86M | -$59.9M | $67.9M | -$12.4M | |
Cash From Operations | $166.2M | $41.5M | $132.5M | $266.1M | $132.2M | |
Capital Expenditures | $32.2M | $37.2M | $55.9M | $69.6M | $63.5M | |
Cash Acquisitions | -- | -- | -- | -$34.7M | -$200K | |
Cash From Investing | -$32.2M | -$34.3M | -$55.7M | -$104.1M | -$63.2M | |
Dividends Paid (Ex Special Dividend) | -$25.6M | -$28.8M | -$31.7M | -$35.1M | -$38.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $15M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$76M | -$500K | -- | -- | -- | |
Repurchase of Common Stock | -$600K | -$1.1M | -$5.3M | -$1.2M | -$5.1M | |
Other Financing Activities | -- | -- | -- | -$1.2M | $2.7M | |
Cash From Financing | -$85.5M | -$18.8M | -$34.2M | -$38.9M | -$39.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $48.5M | -$11.6M | $42.6M | $123.1M | $29.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $134M | $4.3M | $76.6M | $196.5M | $68.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $45.8M | $68.8M | $62.1M | $72.6M | $32.8M | |
Depreciation & Amoritzation | $20.6M | $20.8M | $19.2M | $21.5M | $10.9M | |
Stock-Based Compensation | $2.9M | $3.2M | $3.9M | $4.2M | $1.9M | |
Change in Accounts Receivable | -$64.3M | -$62.1M | $26.4M | $54.5M | $6.6M | |
Change in Inventories | -$31.3M | -$88.3M | $19M | -$17.8M | -$6.6M | |
Cash From Operations | $21.6M | -$36.5M | $76.8M | $85.3M | $28.3M | |
Capital Expenditures | $19.5M | $17.4M | $39.3M | $29.7M | $15.6M | |
Cash Acquisitions | -- | -- | -- | -$200K | -- | |
Cash From Investing | -$19.2M | -$17.4M | -$39.3M | -$29.7M | -$15.5M | |
Dividends Paid (Ex Special Dividend) | -$14M | -$15.6M | -$17.2M | -$19M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$300K | -$100K | -- | -- | -- | |
Repurchase of Common Stock | -$800K | -$2.7M | -$1M | -$700K | -$4.8M | |
Other Financing Activities | $100K | -- | -$1.3M | $500K | $800K | |
Cash From Financing | -$13.3M | -$16.3M | -$18.8M | -$18.4M | -$3.8M | |
Beginning Cash (CF) | $222.3M | $247.4M | $294.6M | $473.8M | $289.2M | |
Foreign Exchange Rate Adjustment | -- | -$200K | $100K | -$700K | $1.6M | |
Additions / Reductions | -$10.9M | -$70.2M | $18.7M | $37.2M | $9M | |
Ending Cash (CF) | $211.4M | $177M | $313.4M | $510.3M | $299.8M | |
Levered Free Cash Flow | $2.1M | -$53.9M | $37.5M | $55.6M | $12.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.